Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer
Author(s)
Miller, AR;
Details
Publication Year 2023-02,Volume 28,Issue #2,Page 101-106
Journal Title
Respirology
Publication Type
Commentary
Publisher
Wiley
Keywords
Humans; *Lung Neoplasms/drug therapy; *Carcinoma, Non-Small-Cell Lung/drug therapy; Immunotherapy; T cell biology; animal models; basic science; checkpoint inhibitors
Department(s)
Clinical Services
PubMed ID
36535890
Open Access at Publisher's Site
https://doi.org/10.1111/resp.14437
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-06-06 06:44:08
Last Modified: 2023-06-06 06:45:18

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙